Finance

Lists
300497:SHE
Jiangxi Fushine Pharmaceutical Co Ltd
CNÂ¥19.03
+1.71%
(+0.32) 1D
Sep 8, 3:04:31 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300497...
Open
CNÂ¥18.98
High
CNÂ¥19.20
Low
CNÂ¥18.79
Mkt. cap
9.85B
Avg. vol.
30.63M
Volume
29.05M
Dividend
0.26%
Quarterly dividend
CNÂ¥0.01
Ex-dividend date
Aug 24, 2026
P/E ratio
81.51
52-wk high
CNÂ¥24.18
52-wk low
CNÂ¥9.40
EPS
CNÂ¥0.23
Shares outstanding
538.65M
No. of employees
2K
Open
CNÂ¥18.98
High
CNÂ¥19.20
Low
CNÂ¥18.79
Mkt. cap
9.85B
Avg. vol.
30.63M
Volume
29.05M
Dividend
0.26%
Quarterly dividend
CNÂ¥0.01
Ex-dividend date
Aug 24, 2026
P/E ratio
81.51
52-wk high
CNÂ¥24.18
52-wk low
CNÂ¥9.40
EPS
CNÂ¥0.23
Shares outstanding
538.65M
No. of employees
2K
About Jiangxi Fushine Pharmaceutical Co Ltd
CEO-
Employees1.66K
FoundedMar 20, 2002
Headquarters-
SectorPharmaceutical industry
Websitefushine.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
254.68M
415.64M
357.76M
530.49M
Cost of goods sold
247.32M
318.51M
220.70M
331.53M
Cost of revenue
247.32M
318.51M
220.70M
331.53M
Research and development expenses
14.18M
15.40M
12.98M
22.08M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
36.98M
49.14M
36.10M
42.99M
Operating expense
21.00M
107.93M
58.20M
71.21M
Total operating expenses
268.31M
426.44M
278.89M
402.75M
Operating income
-13.64M
-10.80M
78.87M
127.74M
Other non operating income
-3.94M
5.39M
-5.89M
1.71M
EBT including unusual items
-58.83M
-3.56M
59.20M
111.14M
EBT excluding unusual items
-26.33M
-24.11M
61.52M
110.06M
Income tax expense
-1.14M
-8.28M
-263.12K
-1.51M
Effective tax rate
1.93%
232.34%
-0.44%
-1.36%
Other operating expenses
-27.78M
34.37M
4.09M
950.12K
Net income
-55.84M
7.73M
61.20M
115.75M
Net profit margin
-21.93%
1.86%
17.11%
21.82%
Earnings per share
-
-
-
-
Interest and investment income
1.33M
997.56K
764.06K
1.18M
Interest expense
-9.91M
-16.38M
-12.22M
-11.11M
Net interest expenses
-8.57M
-15.38M
-11.46M
-9.93M
Depreciation and amortization charges
-
-
-
-
EBITDA
29.04M
35.99M
125.66M
177.38M
Gain or loss from assets sale
13.58K
377.06K
-
-2.64K
AI content may include mistakes. Learn more
Google apps